| 10-Q |
Report
| Data |
10-Q |
Nov 6, 2024 |
Sep 30, 2024 |
| 8-K |
Report
| Data |
FORM 8-K |
Nov 6, 2024 |
Nov 6, 2024 |
| 10-Q |
Report
| Data |
10-Q |
Jul 31, 2024 |
Jun 30, 2024 |
| 8-K |
Report
| Data |
FORM 8-K |
Jul 31, 2024 |
Jul 31, 2024 |
| 8-K |
Report
| Data |
8-K |
Jun 25, 2024 |
Jun 23, 2024 |
| 8-K |
Report
| Data |
8-K |
Jun 6, 2024 |
Jun 6, 2024 |
| 8-K |
Report
| Data |
8-K |
May 15, 2024 |
May 15, 2024 |
| 10-Q |
Report
| Data |
10-Q |
May 8, 2024 |
Mar 31, 2024 |
| 8-K |
Report
| Data |
8-K |
May 8, 2024 |
May 8, 2024 |
| 8-K |
Report
| Data |
8-K |
Apr 18, 2024 |
Apr 18, 2024 |
| SC 13G/A |
Report
|
SC 13-G/A |
Apr 9, 2024 |
|
| 10-K |
Report
| Data |
10-K |
Feb 12, 2024 |
Dec 31, 2023 |
| SC 13G |
Report
|
SC 13-G |
Feb 1, 2024 |
|
| 8-K |
Report
| Data |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K |
Jan 31, 2024 |
Jan 31, 2024 |
| 10-Q |
Report
| Data |
10-Q |
Nov 9, 2023 |
Sep 30, 2023 |
| 8-K |
Report
| Data |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K |
Nov 8, 2023 |
Nov 8, 2023 |
| 8-K |
Report
| Data |
8-K |
Oct 4, 2023 |
Oct 4, 2023 |
| 8-K |
Report
| Data |
8-K |
Sep 28, 2023 |
Sep 25, 2023 |
| 8-K |
Report
| Data |
8-K |
Aug 24, 2023 |
Aug 21, 2023 |
| 8-K |
Report
| Data |
8-K |
Aug 2, 2023 |
Aug 1, 2023 |
| 10-Q |
Report
| Data |
10-Q |
Aug 2, 2023 |
Jun 30, 2023 |
| 8-K |
Report
| Data |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K |
Aug 2, 2023 |
Aug 2, 2023 |
| 8-K |
Report
| Data |
8-K |
Jun 15, 2023 |
Jun 15, 2023 |
| SC 13G/A |
Report
|
SEC SCHEDULE 13G |
Jun 9, 2023 |
|
| 8-K |
Report
| Data |
8-K |
Jun 8, 2023 |
Jun 8, 2023 |
| 8-K |
Report
| Data |
8-K |
May 11, 2023 |
May 8, 2023 |
| 10-Q |
Report
| Data |
10-Q |
May 10, 2023 |
Mar 31, 2023 |
| 8-K |
Report
| Data |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K |
May 10, 2023 |
May 10, 2023 |
| 8-K |
Report
| Data |
8-K |
Mar 9, 2023 |
Mar 9, 2023 |
| 8-K |
Report
| Data |
8-K |
Mar 3, 2023 |
Mar 1, 2023 |
| SC 13G/A |
Report
|
SEC SCHEDULE 13G |
Feb 13, 2023 |
|
| 10-K |
Report
| Data |
FORM 10-K |
Feb 10, 2023 |
Dec 31, 2022 |
| 8-K |
Report
| Data |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K |
Feb 8, 2023 |
Feb 8, 2023 |
| 8-K |
Report
| Data |
8-K |
Nov 21, 2022 |
Nov 18, 2022 |
| 10-Q |
Report
| Data |
10-Q |
Nov 3, 2022 |
Sep 30, 2022 |
| 8-K |
Report
| Data |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K |
Nov 3, 2022 |
Nov 3, 2022 |
| 10-Q |
Report
| Data |
10-Q |
Jul 27, 2022 |
Jun 30, 2022 |
| 8-K |
Report
| Data |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K |
Jul 26, 2022 |
Jul 26, 2022 |
| 8-K |
Report
| Data |
8-K |
Jun 23, 2022 |
Jun 23, 2022 |
| 10-Q |
Report
| Data |
10-Q |
May 3, 2022 |
Mar 31, 2022 |
| 8-K |
Report
| Data |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K |
May 3, 2022 |
May 3, 2022 |
| 8-K |
Report
| Data |
8-K |
Feb 24, 2022 |
Feb 24, 2022 |
| SC 13G/A |
Report
|
SEC SCHEDULE 13G |
Feb 11, 2022 |
|
| 10-K |
Report
| Data |
FORM 10-K |
Feb 9, 2022 |
Dec 31, 2021 |
| 8-K |
Report
| Data |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K |
Feb 9, 2022 |
Feb 9, 2022 |
| 8-K |
Report
| Data |
8-K |
Nov 24, 2021 |
Nov 22, 2021 |
| 8-K |
Report
| Data |
8-K |
Nov 10, 2021 |
Nov 9, 2021 |
| 8-K |
Report
| Data |
8-K |
Nov 4, 2021 |
Nov 2, 2021 |
| 8-K |
Report
| Data |
8-K |
Nov 2, 2021 |
Nov 2, 2021 |
| 10-Q |
Report
| Data |
10-Q |
Oct 27, 2021 |
Sep 30, 2021 |
| 8-K |
Report
| Data |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K |
Oct 27, 2021 |
Sep 30, 2021 |
| 8-K |
Report
| Data |
8-K |
Aug 27, 2021 |
Aug 26, 2021 |
| 10-Q |
Report
| Data |
10-Q |
Jul 28, 2021 |
Jun 30, 2021 |
| 8-K |
Report
| Data |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K |
Jul 28, 2021 |
Jun 30, 2021 |
| 8-K |
Report
| Data |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K |
Jul 21, 2021 |
Jul 21, 2021 |
| 8-K |
Report
| Data |
8-K |
Jul 6, 2021 |
Jul 2, 2021 |
| 8-K |
Report
| Data |
8-K |
Jun 14, 2021 |
Jun 14, 2021 |
| 10-Q |
Report
| Data |
10-Q |
Apr 28, 2021 |
Mar 31, 2021 |
| 8-K |
Report
| Data |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K |
Apr 28, 2021 |
Mar 31, 2021 |
| SC 13G/A |
Report
|
SEC SCHEDULE 13G |
Feb 16, 2021 |
|
| SC 13G |
Report
|
SC 13G |
Feb 11, 2021 |
|
| 10-K |
Report
| Data |
FORM 10-K |
Feb 10, 2021 |
Dec 31, 2020 |
| 8-K |
Report
| Data |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K |
Feb 10, 2021 |
Feb 10, 2021 |
| SC 13G/A |
Report
|
SEC SCHEDULE 13G |
Feb 3, 2021 |
|
| 8-K |
Report
| Data |
8-K |
Feb 2, 2021 |
Jan 31, 2021 |
| 8-K |
Report
| Data |
8-K |
Jan 25, 2021 |
Jan 21, 2021 |
| 10-Q |
Report
| Data |
10-Q |
Nov 5, 2020 |
Sep 30, 2020 |
| 8-K |
Report
| Data |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K |
Nov 5, 2020 |
Nov 5, 2020 |
| 8-K |
Report
| Data |
8-K |
Aug 6, 2020 |
Aug 4, 2020 |
| 10-Q |
Report
| Data |
10-Q |
Aug 5, 2020 |
Jun 30, 2020 |
| 8-K |
Report
| Data |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K |
Aug 5, 2020 |
Aug 5, 2020 |
| 8-K |
Report
| Data |
8-K |
Jun 9, 2020 |
Jun 9, 2020 |
| 10-Q |
Report
| Data |
10-Q |
May 7, 2020 |
Mar 31, 2020 |
| 8-K |
Report
| Data |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K |
May 7, 2020 |
May 7, 2020 |
| 10-K |
Report
| Data |
FORM 10-K |
Feb 21, 2020 |
Dec 31, 2019 |
| SC 13G/A |
Report
|
SC 13G/A |
Feb 14, 2020 |
|
| 8-K |
Report
| Data |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K |
Feb 12, 2020 |
Feb 12, 2020 |
| SC 13G/A |
Report
|
|
Feb 5, 2020 |
|
| SC 13G |
Report
|
SEC SCHEDULE 13G |
Jan 28, 2020 |
|
| 8-K |
Report
| Data |
FORM 8-K |
Nov 25, 2019 |
Nov 25, 2019 |
| 10-Q |
Report
| Data |
FORM 10-Q |
Nov 7, 2019 |
Sep 30, 2019 |
| 8-K |
Report
| Data |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K |
Nov 7, 2019 |
Nov 7, 2019 |
| 8-K |
Report
| Data |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K |
Nov 7, 2019 |
Nov 7, 2019 |
| 8-K |
Report
| Data |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K |
Oct 23, 2019 |
Oct 21, 2019 |
| 8-K |
Report
| Data |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K |
Oct 2, 2019 |
Oct 2, 2019 |
| 10-Q |
Report
| Data |
FORM 10-Q |
Aug 7, 2019 |
Jun 30, 2019 |
| 8-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K |
Aug 7, 2019 |
Aug 7, 2019 |
| 8-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K |
Aug 7, 2019 |
Aug 7, 2019 |
| 8-K |
Report
|
8-K |
Jun 11, 2019 |
Jun 11, 2019 |
| 10-Q |
Report
| Data |
FORM 10-Q |
May 2, 2019 |
Mar 31, 2019 |
| 8-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LTD. 8-K |
May 2, 2019 |
May 2, 2019 |
| 8-K |
Report
|
FORM 8-K |
Apr 10, 2019 |
Apr 8, 2019 |
| 10-K |
Report
| Data |
FORM 10-K |
Feb 19, 2019 |
Dec 31, 2018 |
| SC 13G |
Report
|
SC 13G |
Feb 14, 2019 |
|
| SC 13G/A |
Report
|
SC 13G/A |
Feb 14, 2019 |
|
| 8-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K |
Feb 13, 2019 |
Feb 13, 2019 |
| SC 13G/A |
Report
|
|
Jan 28, 2019 |
|
| 8-K |
Report
|
FORM 8-K |
Dec 14, 2018 |
Dec 14, 2018 |
| 8-K |
Report
|
FORM 8-K |
Dec 4, 2018 |
Dec 4, 2018 |
| 8-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K |
Nov 26, 2018 |
Nov 26, 2018 |
| 10-Q |
Report
| Data |
FORM 10-Q |
Nov 1, 2018 |
Sep 30, 2018 |
| 8-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K |
Nov 1, 2018 |
Nov 1, 2018 |
| 10-Q |
Report
| Data |
FORM 10-Q |
Aug 2, 2018 |
Jun 30, 2018 |
| 8-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K |
Aug 2, 2018 |
Aug 2, 2018 |
| 8-K |
Report
|
FORM 8-K |
Jun 6, 2018 |
Jun 5, 2018 |
| 10-Q |
Report
| Data |
10-Q |
May 3, 2018 |
Mar 31, 2018 |
| 8-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K |
May 3, 2018 |
May 3, 2018 |
| 8-K |
Report
|
FORM 8-K |
Apr 27, 2018 |
Apr 27, 2018 |
| 8-K |
Report
|
FORM 8-K |
Mar 14, 2018 |
Mar 14, 2018 |
| SC 13G/A |
Report
|
|
Feb 13, 2018 |
|
| SC 13D/A |
Report
|
SCHEDULE 13D AMENDMENT NO. 4 |
Feb 12, 2018 |
|
| 10-K |
Report
| Data |
FORM 10-K |
Feb 12, 2018 |
Dec 31, 2017 |
| SC 13G/A |
Report
|
SC 13G/A |
Feb 9, 2018 |
|
| SC 13G |
Report
|
SC 13G |
Feb 9, 2018 |
|
| 8-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LTD. 8-K |
Feb 8, 2018 |
Feb 8, 2018 |
| SC 13G |
Report
|
|
Feb 5, 2018 |
|
| 8-K |
Report
|
FORM 8-K |
Feb 1, 2018 |
Feb 1, 2018 |
| 8-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K |
Feb 1, 2018 |
Feb 1, 2018 |
| SC 13D/A |
Report
|
SCHEDULE 13D AMENDMENT NO. 3 |
Jan 12, 2018 |
|
| 8-K |
Report
|
FORM 8-K |
Jan 4, 2018 |
Jan 4, 2018 |
| 8-K |
Report
|
8-K |
Jan 3, 2018 |
Jan 2, 2018 |
| 6-K |
Report
|
LIVE FILING |
Dec 27, 2017 |
Dec 27, 2017 |
| 6-K |
Report
|
LIVE FILING |
Dec 18, 2017 |
Dec 18, 2017 |
| 6-K |
Report
|
LIVE FILING |
Dec 15, 2017 |
Dec 15, 2017 |
| 6-K |
Report
|
FORM 6-K |
Dec 14, 2017 |
Dec 14, 2017 |
| 6-K |
Report
|
LIVE FILING |
Dec 13, 2017 |
Dec 13, 2017 |
| 6-K |
Report
|
LIVE FILING |
Dec 12, 2017 |
Dec 12, 2017 |
| 6-K |
Report
|
LIVE FILING |
Dec 11, 2017 |
Dec 11, 2017 |
| 6-K |
Report
|
LIVE FILING |
Nov 29, 2017 |
Nov 29, 2017 |
| 6-K |
Report
|
LIVE FILING |
Nov 27, 2017 |
Nov 27, 2017 |
| SC 13D/A |
Report
|
SC 13D/A |
Nov 13, 2017 |
|
| 6-K |
Report
| Data |
FORM 6-K |
Nov 2, 2017 |
Nov 2, 2017 |
| 6-K |
Report
|
LIVE FILING |
Nov 2, 2017 |
Nov 2, 2017 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K |
Nov 2, 2017 |
Nov 2, 2017 |
| SC 13D/A |
Report
|
SC 13D/A |
Nov 1, 2017 |
|
| 6-K |
Report
|
LIVE FILING |
Nov 1, 2017 |
Nov 1, 2017 |
| 6-K |
Report
|
LIVE FILING |
Oct 31, 2017 |
Oct 31, 2017 |
| SC 13G/A |
Report
|
SC 13G/A |
Oct 31, 2017 |
|
| SC 13G |
Report
|
SC 13G |
Oct 31, 2017 |
|
| 6-K |
Report
|
LIVE FILING |
Oct 30, 2017 |
Oct 30, 2017 |
| 6-K |
Report
|
LIVE FILING |
Oct 26, 2017 |
Oct 26, 2017 |
| 6-K |
Report
|
LIVE FILING |
Oct 19, 2017 |
Oct 19, 2017 |
| 6-K |
Report
|
LIVE FILING |
Oct 17, 2017 |
Oct 17, 2017 |
| 6-K |
Report
|
LIVE FILING |
Oct 10, 2017 |
Oct 10, 2017 |
| 6-K |
Report
|
LIVE FILING |
Oct 4, 2017 |
Oct 4, 2017 |
| 6-K |
Report
|
LIVE FILING |
Sep 25, 2017 |
Sep 25, 2017 |
| 6-K |
Report
|
LIVE FILING |
Sep 25, 2017 |
Sep 25, 2017 |
| 6-K |
Report
|
FORM 6-K |
Sep 19, 2017 |
Sep 19, 2017 |
| 6-K |
Report
|
LIVE FILING |
Sep 19, 2017 |
Sep 19, 2017 |
| 6-K |
Report
|
LIVE FILING |
Sep 18, 2017 |
Sep 18, 2017 |
| 6-K |
Report
|
LIVE FILING |
Sep 18, 2017 |
Sep 18, 2017 |
| 6-K |
Report
|
LIVE FILING |
Sep 14, 2017 |
Sep 14, 2017 |
| 6-K |
Report
|
LIVE FILING |
Sep 12, 2017 |
Sep 12, 2017 |
| 6-K |
Report
|
LIVE FILING |
Sep 11, 2017 |
Sep 11, 2017 |
| 6-K |
Report
|
LIVE FILING |
Sep 11, 2017 |
Sep 11, 2017 |
| 6-K |
Report
|
|
Sep 11, 2017 |
Sep 11, 2017 |
| 6-K |
Report
|
LIVE FILING |
Sep 6, 2017 |
Sep 6, 2017 |
| SC 13D/A |
Report
|
SC 13D/A |
Sep 5, 2017 |
|
| 6-K |
Report
|
LIVE FILING |
Sep 5, 2017 |
Sep 5, 2017 |
| 6-K |
Report
|
LIVE FILING |
Aug 30, 2017 |
Aug 30, 2017 |
| 6-K |
Report
|
LIVE FILING |
Aug 18, 2017 |
Aug 18, 2017 |
| 6-K |
Report
|
LIVE FILING |
Aug 7, 2017 |
Aug 7, 2017 |
| 6-K |
Report
| Data |
FORM 6-K |
Aug 3, 2017 |
Aug 3, 2017 |
| 6-K |
Report
| Data |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K |
Aug 3, 2017 |
Aug 3, 2017 |
| 6-K |
Report
| Data |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K |
Jul 31, 2017 |
Jul 31, 2017 |
| 6-K |
Report
| Data |
LIVE FILING |
Jul 28, 2017 |
Jul 28, 2017 |
| 6-K |
Report
| Data |
LIVE FILING |
Jul 24, 2017 |
Jul 24, 2017 |
| 6-K |
Report
| Data |
LIVE FILING |
Jul 20, 2017 |
Jul 20, 2017 |
| 6-K |
Report
|
LIVE FILING |
Jul 13, 2017 |
Jul 13, 2017 |
| 6-K |
Report
|
LIVE FILING |
Jul 11, 2017 |
Jul 11, 2017 |
| 6-K |
Report
|
LIVE FILING |
Jul 11, 2017 |
Jul 11, 2017 |
| 6-K |
Report
|
LIVE FILING |
Jun 29, 2017 |
Jun 29, 2017 |
| 6-K |
Report
|
LIVE FILING |
Jun 29, 2017 |
Jun 29, 2017 |
| 6-K |
Report
|
LIVE FILING |
Jun 27, 2017 |
Jun 27, 2017 |
| 6-K |
Report
|
LIVE FILING |
Jun 12, 2017 |
Jun 12, 2017 |
| 6-K |
Report
|
LIVE FILING |
Jun 9, 2017 |
Jun 9, 2017 |
| 6-K |
Report
|
FORM 6-K |
Jun 8, 2017 |
Jun 8, 2017 |
| 6-K |
Report
|
LIVE FILING |
Jun 7, 2017 |
Jun 7, 2017 |
| 6-K |
Report
|
LIVE FILING |
Jun 6, 2017 |
Jun 6, 2017 |
| 6-K |
Report
|
LIVE FILING |
Jun 1, 2017 |
Jun 1, 2017 |
| 6-K |
Report
|
LIVE FILING |
May 31, 2017 |
May 31, 2017 |
| 6-K |
Report
|
LIVE FILING |
May 17, 2017 |
May 17, 2017 |
| 6-K |
Report
|
LIVE FILING |
May 17, 2017 |
May 17, 2017 |
| 6-K |
Report
|
LIVE FILING |
May 15, 2017 |
May 15, 2017 |
| 6-K |
Report
|
LIVE FILING |
May 15, 2017 |
May 15, 2017 |
| 6-K |
Report
| Data |
FORM 6-K |
May 11, 2017 |
May 11, 2017 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K |
May 11, 2017 |
May 11, 2017 |
| 6-K |
Report
|
LIVE FILING |
May 5, 2017 |
May 5, 2017 |
| 6-K |
Report
|
LIVE FILING |
May 5, 2017 |
May 5, 2017 |
| 6-K |
Report
|
LIVE FILING |
Apr 27, 2017 |
Apr 27, 2017 |
| 6-K |
Report
|
LIVE FILING |
Apr 26, 2017 |
Apr 26, 2017 |
| 6-K |
Report
|
LIVE FILING |
Apr 26, 2017 |
Apr 26, 2017 |
| 6-K |
Report
|
LIVE FILING |
Apr 20, 2017 |
Apr 20, 2017 |
| 6-K |
Report
|
LIVE FILING |
Apr 19, 2017 |
Apr 19, 2017 |
| 6-K |
Report
|
LIVE FILING |
Apr 13, 2017 |
Apr 13, 2017 |
| 6-K |
Report
|
LIVE FILING |
Apr 6, 2017 |
Apr 6, 2017 |
| 6-K |
Report
|
LIVE FILING |
Apr 3, 2017 |
Apr 3, 2017 |
| 6-K |
Report
|
LIVE FILING |
Mar 16, 2017 |
Mar 16, 2017 |
| 6-K |
Report
|
LIVE FILING |
Mar 13, 2017 |
Mar 13, 2017 |
| 6-K |
Report
|
LIVE FILING |
Mar 6, 2017 |
Mar 6, 2017 |
| 6-K |
Report
|
LIVE FILING |
Mar 1, 2017 |
Mar 1, 2017 |
| 6-K |
Report
|
LIVE FILING |
Feb 28, 2017 |
Feb 28, 2017 |
| 6-K |
Report
|
FORM 6-K |
Feb 16, 2017 |
Feb 15, 2017 |
| 20-F |
Report
| Data |
FORM 20-F |
Feb 15, 2017 |
Dec 31, 2016 |
| SC 13G/A |
Report
|
|
Feb 14, 2017 |
|
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K |
Feb 13, 2017 |
Feb 13, 2017 |
| 6-K |
Report
|
LIVE FILING |
Feb 6, 2017 |
Feb 6, 2017 |
| 6-K |
Report
|
LIVE FILING |
Feb 2, 2017 |
Feb 2, 2017 |
| 6-K |
Report
|
LIVE FILING |
Feb 1, 2017 |
Feb 1, 2017 |
| 6-K |
Report
|
LIVE FILING |
Jan 31, 2017 |
Jan 31, 2017 |
| 6-K |
Report
|
LIVE FILING |
Jan 30, 2017 |
Jan 30, 2017 |
| 6-K |
Report
|
LIVE FILING |
Jan 26, 2017 |
Jan 26, 2017 |
| 6-K |
Report
|
LIVE FILING |
Jan 18, 2017 |
Jan 18, 2017 |
| 6-K |
Report
|
LIVE FILING |
Jan 9, 2017 |
Jan 9, 2017 |
| 6-K |
Report
|
LIVE FILING |
Jan 6, 2017 |
Jan 6, 2017 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K |
Jan 6, 2017 |
Jan 6, 2017 |
| 6-K |
Report
|
LIVE FILING |
Jan 5, 2017 |
Jan 5, 2017 |
| 6-K |
Report
|
LIVE FILING |
Dec 22, 2016 |
Dec 22, 2016 |
| 6-K |
Report
|
LIVE FILING |
Dec 7, 2016 |
Dec 7, 2016 |
| 6-K |
Report
|
LIVE FILING |
Dec 6, 2016 |
Dec 6, 2016 |
| 6-K |
Report
|
LIVE FILING |
Dec 6, 2016 |
Dec 6, 2016 |
| 6-K |
Report
|
LIVE FILING |
Dec 5, 2016 |
Dec 5, 2016 |
| 6-K |
Report
|
LIVE FILING |
Nov 30, 2016 |
Nov 30, 2016 |
| 6-K |
Report
|
LIVE FILING |
Nov 21, 2016 |
Nov 21, 2016 |
| 6-K |
Report
| Data |
FORM 6-K |
Nov 15, 2016 |
Nov 15, 2016 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K |
Nov 15, 2016 |
Nov 15, 2016 |
| 6-K |
Report
|
LIVE FILING |
Nov 8, 2016 |
Nov 8, 2016 |
| 6-K |
Report
|
LIVE FILING |
Nov 7, 2016 |
Nov 7, 2016 |
| 6-K |
Report
|
LIVE FILING |
Nov 7, 2016 |
Nov 7, 2016 |
| 6-K |
Report
|
LIVE FILING |
Nov 2, 2016 |
Nov 2, 2016 |
| 6-K |
Report
|
LIVE FILING |
Oct 31, 2016 |
Oct 31, 2016 |
| 6-K |
Report
|
LIVE FILING |
Oct 26, 2016 |
Oct 26, 2016 |
| 6-K |
Report
|
LIVE FILING |
Oct 20, 2016 |
Oct 20, 2016 |
| 6-K |
Report
|
6-K |
Oct 18, 2016 |
Oct 18, 2016 |
| 6-K |
Report
|
LIVE FILING |
Oct 17, 2016 |
Oct 17, 2016 |
| 6-K |
Report
|
LIVE FILING |
Oct 17, 2016 |
Oct 17, 2016 |
| 6-K |
Report
|
LIVE FILING |
Oct 12, 2016 |
Oct 12, 2016 |
| 6-K |
Report
|
LIVE FILING |
Oct 6, 2016 |
Oct 6, 2016 |
| 6-K |
Report
|
LIVE FILING |
Oct 5, 2016 |
Oct 5, 2016 |
| 6-K |
Report
|
LIVE FILING |
Oct 3, 2016 |
Oct 3, 2016 |
| 6-K/A |
Report
|
FORM 6-K AMENDMENT |
Sep 30, 2016 |
Sep 29, 2016 |
| 6-K |
Report
|
LIVE FILING |
Sep 28, 2016 |
Sep 28, 2016 |
| 6-K |
Report
|
LIVE FILING |
Sep 22, 2016 |
Sep 22, 2016 |
| 6-K |
Report
|
LIVE FILING |
Sep 20, 2016 |
Sep 20, 2016 |
| 6-K |
Report
|
LIVE FILING |
Sep 19, 2016 |
Sep 19, 2016 |
| 6-K |
Report
|
LIVE FILING |
Sep 15, 2016 |
Sep 15, 2016 |
| 6-K |
Report
|
6-K |
Sep 9, 2016 |
Sep 9, 2016 |
| 6-K |
Report
|
LIVE FILING |
Sep 7, 2016 |
Sep 7, 2016 |
| 6-K |
Report
|
LIVE FILING |
Sep 6, 2016 |
Sep 6, 2016 |
| 6-K |
Report
|
LIVE FILING |
Aug 30, 2016 |
Aug 30, 2016 |
| 6-K |
Report
|
LIVE FILING |
Aug 29, 2016 |
Aug 29, 2016 |
| 6-K |
Report
|
LIVE FILING |
Aug 25, 2016 |
Aug 25, 2016 |
| 6-K |
Report
|
LIVE FILING |
Aug 18, 2016 |
Aug 18, 2016 |
| SC 13D |
Report
|
SC 13D |
Aug 8, 2016 |
|
| 6-K |
Report
|
LIVE FILING |
Aug 5, 2016 |
Aug 5, 2016 |
| 6-K |
Report
| Data |
FORM 6-K |
Aug 4, 2016 |
Aug 4, 2016 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES 6-K |
Aug 4, 2016 |
Aug 4, 2016 |
| 6-K |
Report
|
LIVE FILING |
Aug 3, 2016 |
Aug 3, 2016 |
| 6-K |
Report
|
LIVE FILING |
Aug 2, 2016 |
Aug 2, 2016 |
| 6-K |
Report
|
FORM 6-K |
Jul 28, 2016 |
Jul 28, 2016 |
| 6-K |
Report
|
LIVE FILING |
Jul 27, 2016 |
Jul 27, 2016 |
| 6-K |
Report
|
LIVE FILING |
Jul 27, 2016 |
Jul 27, 2016 |
| 6-K |
Report
|
FORM 6-K |
Jul 25, 2016 |
Jul 25, 2016 |
| 6-K |
Report
|
FORM 6-K |
Jul 21, 2016 |
Jul 21, 2016 |
| 6-K |
Report
|
FORM 6-K |
Jul 21, 2016 |
Jul 21, 2016 |
| 6-K |
Report
|
FORM 6-K |
Jul 20, 2016 |
Jul 20, 2016 |
| 6-K |
Report
|
FORM 6-K |
Jul 13, 2016 |
Jul 13, 2016 |
| 6-K |
Report
|
FORM 6-K |
Jul 13, 2016 |
Jul 13, 2016 |
| 6-K |
Report
|
FORM 6-K |
Jul 13, 2016 |
Jul 12, 2016 |
| 6-K |
Report
|
LIVE FILING |
Jul 12, 2016 |
Jul 12, 2016 |
| 6-K |
Report
|
LIVE FILING |
Jul 5, 2016 |
Jul 5, 2016 |
| 6-K |
Report
|
LIVE FILING |
Jun 28, 2016 |
Jun 28, 2016 |
| 6-K |
Report
|
LIVE FILING |
Jun 27, 2016 |
Jun 27, 2016 |
| 6-K |
Report
|
LIVE FILING |
Jun 24, 2016 |
Jun 24, 2016 |
| 6-K |
Report
|
LIVE FILING |
Jun 23, 2016 |
Jun 23, 2016 |
| 6-K |
Report
| Data |
LIVE FILING |
Jun 20, 2016 |
Jun 20, 2016 |
| 6-K |
Report
| Data |
LIVE FILING |
Jun 13, 2016 |
Jun 13, 2016 |
| 6-K |
Report
| Data |
LIVE FILING |
Jun 10, 2016 |
Jun 10, 2016 |
| 6-K |
Report
| Data |
LIVE FILING |
Jun 7, 2016 |
Jun 7, 2016 |
| 6-K |
Report
| Data |
LIVE FILING |
Jun 7, 2016 |
Jun 7, 2016 |
| 6-K |
Report
| Data |
LIVE FILING |
Jun 6, 2016 |
Jun 6, 2016 |
| 6-K |
Report
| Data |
LIVE FILING |
May 31, 2016 |
May 31, 2016 |
| 6-K |
Report
| Data |
LIVE FILING |
May 31, 2016 |
May 31, 2016 |
| 6-K |
Report
| Data |
LIVE FILING |
May 12, 2016 |
May 12, 2016 |
| 6-K |
Report
| Data |
LIVE FILING |
May 9, 2016 |
May 9, 2016 |
| 6-K |
Report
| Data |
6-K |
May 9, 2016 |
May 9, 2016 |
| 6-K |
Report
| Data |
TEVA PHARMACEUTICAL INDUSTRIES LTD. 6-K |
May 9, 2016 |
May 9, 2016 |
| 6-K |
Report
| Data |
LIVE FILING |
Apr 29, 2016 |
Apr 29, 2016 |
| 6-K |
Report
|
FORM 6-K |
Apr 18, 2016 |
Apr 18, 2016 |
| 6-K |
Report
| Data |
LIVE FILING |
Apr 18, 2016 |
Apr 18, 2016 |
| 6-K |
Report
| Data |
LIVE FILING |
Apr 18, 2016 |
Apr 18, 2016 |
| 6-K |
Report
| Data |
LIVE FILING |
Apr 12, 2016 |
Apr 12, 2016 |
| 6-K |
Report
| Data |
LIVE FILING |
Apr 1, 2016 |
Apr 1, 2016 |
| 6-K |
Report
|
LIVE FILING |
Apr 1, 2016 |
Apr 1, 2016 |
| SC 13G |
Report
| Data |
SCHEDULE 13G |
Mar 30, 2016 |
|
| SC 13G |
Report
| Data |
SCHEDULE 13G |
Mar 28, 2016 |
|
| 6-K |
Report
| Data |
LIVE FILING |
Mar 23, 2016 |
Mar 23, 2016 |
| 6-K |
Report
| Data |
LIVE FILING |
Mar 22, 2016 |
Mar 22, 2016 |
| 6-K |
Report
|
6-K |
Mar 15, 2016 |
Mar 15, 2016 |
| 6-K |
Report
|
6-K |
Mar 14, 2016 |
Mar 14, 2016 |
| 6-K |
Report
|
LIVE FILING |
Mar 11, 2016 |
Mar 11, 2016 |
| 6-K |
Report
|
LIVE FILING |
Mar 10, 2016 |
Mar 10, 2016 |
| 6-K |
Report
|
LIVE FILING |
Mar 9, 2016 |
Mar 9, 2016 |
| 6-K |
Report
|
LIVE FILING |
Mar 3, 2016 |
Mar 3, 2016 |
| 6-K |
Report
|
LIVE FILING |
Mar 3, 2016 |
Mar 3, 2016 |
| 6-K |
Report
|
LIVE FILING |
Mar 2, 2016 |
Mar 2, 2016 |
| 6-K |
Report
|
FORM 6-K |
Feb 29, 2016 |
Feb 29, 2016 |
| 6-K |
Report
|
LIVE FILING |
Feb 24, 2016 |
Feb 24, 2016 |
| SC 13G |
Report
|
|
Feb 12, 2016 |
|
| 6-K |
Report
|
6-K |
Feb 11, 2016 |
Feb 11, 2016 |
| 20-F |
Report
| Data |
FORM 20-F |
Feb 11, 2016 |
Dec 31, 2015 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K |
Feb 11, 2016 |
Feb 11, 2016 |
| 6-K |
Report
|
LIVE FILING |
Feb 2, 2016 |
Feb 2, 2016 |
| 6-K |
Report
|
LIVE FILING |
Jan 28, 2016 |
Jan 28, 2016 |
| 6-K |
Report
|
LIVE FILING |
Jan 28, 2016 |
Jan 28, 2016 |
| 6-K |
Report
|
LIVE FILING |
Jan 25, 2016 |
Jan 25, 2016 |
| 6-K |
Report
|
LIVE FILING |
Jan 7, 2016 |
Jan 7, 2016 |
| 6-K |
Report
|
LIVE FILING |
Jan 7, 2016 |
Jan 7, 2016 |
| 6-K |
Report
|
FORM 6-K |
Jan 6, 2016 |
Jan 6, 2016 |
| 6-K |
Report
|
LIVE FILING |
Jan 5, 2016 |
Jan 5, 2016 |
| 6-K |
Report
|
LIVE FILING |
Jan 4, 2016 |
Jan 4, 2016 |
| 6-K |
Report
|
LIVE FILING |
Jan 4, 2016 |
Jan 4, 2016 |
| 6-K |
Report
|
LIVE FILING |
Dec 28, 2015 |
Dec 28, 2015 |
| SC 13D |
Report
|
SCHEDULE 13D |
Dec 10, 2015 |
|
| 6-K |
Report
|
LIVE FILING |
Dec 10, 2015 |
Dec 10, 2015 |
| 6-K |
Report
|
FORM 6-K |
Dec 8, 2015 |
Dec 8, 2015 |
| 6-K |
Report
|
LIVE FILING |
Dec 8, 2015 |
Dec 8, 2015 |
| 6-K |
Report
|
LIVE FILING |
Dec 7, 2015 |
Dec 7, 2015 |
| 6-K |
Report
|
LIVE FILING |
Dec 3, 2015 |
Dec 3, 2015 |
| 6-K |
Report
|
FORM 6-K |
Nov 30, 2015 |
Nov 30, 2015 |
| 6-K |
Report
|
FORM 6-K |
Nov 30, 2015 |
Nov 30, 2015 |
| 6-K |
Report
|
FORM 6-K |
Nov 30, 2015 |
Nov 30, 2015 |
| 6-K |
Report
|
LIVE FILING |
Nov 25, 2015 |
Nov 25, 2015 |
| 6-K |
Report
|
LIVE FILING |
Nov 19, 2015 |
Nov 19, 2015 |
| 6-K |
Report
|
LIVE FILING |
Nov 19, 2015 |
Nov 19, 2015 |
| 6-K |
Report
|
FORM 6-K |
Nov 18, 2015 |
Nov 18, 2015 |
| 6-K |
Report
|
LIVE FILING |
Nov 17, 2015 |
Nov 17, 2015 |
| 6-K |
Report
|
LIVE FILING |
Nov 9, 2015 |
Nov 9, 2015 |
| 6-K |
Report
|
FORM 6-K |
Nov 5, 2015 |
Nov 5, 2015 |
| 6-K |
Report
|
LIVE FILING |
Nov 4, 2015 |
Nov 4, 2015 |
| 6-K |
Report
| Data |
6-K |
Oct 29, 2015 |
Oct 29, 2015 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K |
Oct 29, 2015 |
Oct 29, 2015 |
| 6-K |
Report
|
LIVE FILING |
Oct 15, 2015 |
Oct 15, 2015 |
| 6-K |
Report
|
LIVE FILING |
Oct 13, 2015 |
Oct 13, 2015 |
| 6-K |
Report
|
LIVE FILING |
Oct 8, 2015 |
Oct 8, 2015 |
| 6-K |
Report
|
LIVE FILING |
Oct 6, 2015 |
Oct 6, 2015 |
| 6-K |
Report
|
6-K |
Oct 1, 2015 |
Oct 1, 2015 |
| 6-K |
Report
|
LIVE FILING |
Oct 1, 2015 |
Oct 1, 2015 |
| 6-K |
Report
|
LIVE FILING |
Sep 30, 2015 |
Sep 30, 2015 |
| 6-K |
Report
|
FORM 6-K |
Sep 29, 2015 |
Sep 28, 2015 |
| 6-K |
Report
|
LIVE FILING |
Sep 28, 2015 |
Sep 28, 2015 |
| 6-K |
Report
|
LIVE FILING |
Sep 28, 2015 |
Sep 28, 2015 |
| 6-K |
Report
|
LIVE FILING |
Sep 25, 2015 |
Sep 25, 2015 |
| 6-K |
Report
|
LIVE FILING |
Sep 10, 2015 |
Sep 10, 2015 |
| 6-K |
Report
|
LIVE FILING |
Sep 10, 2015 |
Sep 10, 2015 |
| 6-K |
Report
|
LIVE FILING |
Sep 8, 2015 |
Sep 8, 2015 |
| 6-K |
Report
|
LIVE FILING |
Sep 3, 2015 |
Sep 3, 2015 |
| 6-K |
Report
|
LIVE FILING |
Sep 1, 2015 |
Sep 1, 2015 |
| 6-K |
Report
|
LIVE FILING |
Aug 25, 2015 |
Aug 25, 2015 |
| 6-K |
Report
|
LIVE FILING |
Aug 12, 2015 |
Aug 12, 2015 |
| 6-K |
Report
|
FORM 6-K |
Aug 3, 2015 |
Aug 3, 2015 |
| 6-K |
Report
|
LIVE FILING |
Aug 3, 2015 |
Aug 3, 2015 |
| 6-K |
Report
|
LIVE FILING |
Jul 31, 2015 |
Jul 31, 2015 |
| 6-K |
Report
|
6-K |
Jul 30, 2015 |
Jul 30, 2015 |
| 6-K |
Report
| Data |
FORM 6-K |
Jul 30, 2015 |
Jul 30, 2015 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K |
Jul 30, 2015 |
Jul 30, 2015 |
| 6-K |
Report
|
FORM 6-K |
Jul 28, 2015 |
Jul 28, 2015 |
| 6-K |
Report
|
LIVE FILING |
Jul 28, 2015 |
Jul 28, 2015 |
| 6-K |
Report
|
FORM 6-K |
Jul 27, 2015 |
Jul 27, 2015 |
| 6-K |
Report
|
LIVE FILING |
Jul 21, 2015 |
Jul 21, 2015 |
| 6-K |
Report
|
LIVE FILING |
Jul 8, 2015 |
Jul 8, 2015 |
| 6-K |
Report
|
LIVE FILING |
Jul 1, 2015 |
Jul 1, 2015 |
| 6-K |
Report
|
LIVE FILING |
Jul 1, 2015 |
Jul 1, 2015 |
| 6-K |
Report
|
LIVE FILING |
Jun 25, 2015 |
Jun 25, 2015 |
| 6-K |
Report
|
FORM 6-K |
Jun 19, 2015 |
Jun 19, 2015 |
| 6-K |
Report
|
LIVE FILING |
Jun 18, 2015 |
Jun 18, 2015 |
| 6-K |
Report
|
LIVE FILING |
Jun 18, 2015 |
Jun 18, 2015 |
| 6-K |
Report
|
LIVE FILING |
Jun 16, 2015 |
Jun 16, 2015 |
| 6-K |
Report
|
LIVE FILING |
Jun 15, 2015 |
Jun 15, 2015 |
| 6-K |
Report
|
LIVE FILING |
Jun 9, 2015 |
Jun 9, 2015 |
| 6-K |
Report
|
6-K |
Jun 8, 2015 |
Jun 8, 2015 |
| 6-K |
Report
|
LIVE FILING |
Jun 2, 2015 |
Jun 2, 2015 |
| 6-K |
Report
|
LIVE FILING |
Jun 1, 2015 |
Jun 1, 2015 |
| 6-K |
Report
|
LIVE FILING |
May 29, 2015 |
May 29, 2015 |
| 6-K |
Report
|
LIVE FILING |
May 15, 2015 |
May 15, 2015 |
| 6-K |
Report
|
LIVE FILING |
May 14, 2015 |
May 14, 2015 |
| 6-K |
Report
|
LIVE FILING |
May 8, 2015 |
May 8, 2015 |
| 6-K |
Report
|
6-K |
May 5, 2015 |
May 5, 2015 |
| 6-K |
Report
|
FORM 6-K |
May 5, 2015 |
May 5, 2015 |
| 6-K |
Report
| Data |
FORM 6-K |
Apr 30, 2015 |
Apr 30, 2015 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K |
Apr 30, 2015 |
Apr 30, 2015 |
| 6-K |
Report
|
6-K |
Apr 29, 2015 |
Apr 29, 2015 |
| 6-K |
Report
|
LIVE FILING |
Apr 28, 2015 |
Apr 28, 2015 |
| 6-K |
Report
|
LIVE FILING |
Apr 28, 2015 |
Apr 28, 2015 |
| 6-K |
Report
|
6-K |
Apr 27, 2015 |
Apr 27, 2015 |
| 6-K |
Report
|
LIVE FILING |
Apr 23, 2015 |
Apr 23, 2015 |
| 6-K |
Report
|
LIVE FILING |
Apr 23, 2015 |
Apr 23, 2015 |
| 6-K |
Report
|
6-K |
Apr 22, 2015 |
Apr 22, 2015 |
| 6-K |
Report
|
LIVE FILING |
Apr 22, 2015 |
Apr 22, 2015 |
| 6-K |
Report
|
LIVE FILING |
Apr 22, 2015 |
Apr 21, 2015 |
| 6-K |
Report
|
6-K |
Apr 21, 2015 |
Apr 21, 2015 |
| 6-K |
Report
|
LIVE FILING |
Apr 17, 2015 |
Apr 17, 2015 |
| 6-K |
Report
|
LIVE FILING |
Apr 14, 2015 |
Apr 14, 2015 |
| 6-K |
Report
|
LIVE FILING |
Apr 13, 2015 |
Apr 13, 2015 |
| SC 13D |
Report
|
SCHEDULE 13D |
Apr 8, 2015 |
|
| 6-K |
Report
|
LIVE FILING |
Apr 2, 2015 |
Apr 2, 2015 |
| 6-K |
Report
|
LIVE FILING |
Apr 1, 2015 |
Apr 1, 2015 |
| 6-K |
Report
|
FORM 6-K |
Mar 31, 2015 |
Mar 31, 2015 |
| 6-K |
Report
|
LIVE FILING |
Mar 31, 2015 |
Mar 31, 2015 |
| 6-K |
Report
|
LIVE FILING |
Mar 30, 2015 |
Mar 30, 2015 |
| 6-K |
Report
|
LIVE FILING |
Mar 24, 2015 |
Mar 24, 2015 |
| 6-K |
Report
|
LIVE FILING |
Mar 23, 2015 |
Mar 23, 2015 |
| 6-K |
Report
|
LIVE FILING |
Mar 23, 2015 |
Mar 23, 2015 |
| 6-K |
Report
|
LIVE FILING |
Mar 17, 2015 |
Mar 17, 2015 |
| 6-K |
Report
|
LIVE FILING |
Mar 11, 2015 |
Mar 11, 2015 |
| 6-K |
Report
|
LIVE FILING |
Mar 5, 2015 |
Mar 5, 2015 |
| 6-K |
Report
|
LIVE FILING |
Mar 2, 2015 |
Mar 2, 2015 |
| 6-K |
Report
|
LIVE FILING |
Feb 27, 2015 |
Feb 27, 2015 |
| 6-K |
Report
|
LIVE FILING |
Feb 26, 2015 |
Feb 26, 2015 |
| 6-K |
Report
|
LIVE FILING |
Feb 25, 2015 |
Feb 25, 2015 |
| 6-K |
Report
|
LIVE FILING |
Feb 24, 2015 |
Feb 24, 2015 |
| 6-K |
Report
|
LIVE FILING |
Feb 23, 2015 |
Feb 23, 2015 |
| 6-K |
Report
|
LIVE FILING |
Feb 20, 2015 |
Feb 20, 2015 |
| 6-K |
Report
|
LIVE FILING |
Feb 17, 2015 |
Feb 17, 2015 |
| 6-K |
Report
|
LIVE FILING |
Feb 17, 2015 |
Feb 17, 2015 |
| SC 13G/A |
Report
|
SC 13G/A |
Feb 13, 2015 |
|
| 6-K |
Report
|
LIVE FILING |
Feb 12, 2015 |
Feb 12, 2015 |
| 6-K |
Report
|
LIVE FILING |
Feb 10, 2015 |
Feb 10, 2015 |
| 20-F |
Report
| Data |
FORM 20-F |
Feb 9, 2015 |
Dec 31, 2014 |
| 6-K |
Report
|
LIVE FILING |
Feb 5, 2015 |
Feb 5, 2014 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K |
Feb 5, 2015 |
Feb 4, 2015 |
| 6-K |
Report
|
LIVE FILING |
Jan 26, 2015 |
Jan 26, 2015 |
| 6-K |
Report
|
LIVE FILING |
Jan 20, 2015 |
Jan 20, 2014 |
| 6-K |
Report
|
LIVE FILING |
Jan 15, 2015 |
Jan 15, 2015 |
| 6-K |
Report
|
LIVE FILING |
Jan 8, 2015 |
Jan 8, 2015 |
| 6-K |
Report
|
LIVE FILING |
Jan 7, 2015 |
Jan 6, 2014 |
| 6-K |
Report
|
LIVE FILING |
Dec 23, 2014 |
Dec 23, 2014 |
| 6-K |
Report
|
LIVE FILING |
Dec 22, 2014 |
Dec 22, 2014 |
| 6-K |
Report
|
LIVE FILING |
Dec 19, 2014 |
Dec 19, 2014 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K |
Dec 11, 2014 |
Dec 11, 2014 |
| 6-K |
Report
|
LIVE FILING |
Dec 11, 2014 |
Dec 10, 2014 |
| 6-K |
Report
|
LIVE FILING |
Dec 4, 2014 |
Dec 4, 2014 |
| 6-K |
Report
|
LIVE FILING |
Dec 1, 2014 |
Dec 1, 2014 |
| 6-K |
Report
|
LIVE FILING |
Dec 1, 2014 |
Dec 1, 2014 |
| 6-K |
Report
|
LIVE FILING |
Nov 26, 2014 |
Nov 26, 2014 |
| 6-K |
Report
|
LIVE FILING |
Nov 18, 2014 |
Nov 18, 2014 |
| 6-K |
Report
|
LIVE FILING |
Nov 7, 2014 |
Nov 7, 2014 |
| 6-K |
Report
|
LIVE FILING |
Nov 7, 2014 |
Nov 7, 2014 |
| 6-K |
Report
|
LIVE FILING |
Nov 4, 2014 |
Nov 4, 2014 |
| 6-K |
Report
| Data |
FORM 6-K |
Oct 30, 2014 |
Oct 30, 2014 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K |
Oct 30, 2014 |
Oct 30, 2014 |
| 6-K |
Report
|
LIVE FILING |
Oct 8, 2014 |
Oct 8, 2014 |
| 6-K |
Report
|
LIVE FILING |
Oct 6, 2014 |
Oct 6, 2014 |
| 6-K |
Report
|
LIVE FILING |
Oct 6, 2014 |
Oct 6, 2014 |
| 6-K |
Report
|
LIVE FILING |
Sep 12, 2014 |
Sep 12, 2014 |
| 6-K |
Report
|
LIVE FILING |
Sep 12, 2014 |
Sep 12, 2014 |
| 6-K |
Report
|
LIVE FILING |
Sep 11, 2014 |
Sep 11, 2014 |
| 6-K |
Report
|
LIVE FILING |
Sep 8, 2014 |
Sep 8, 2014 |
| 6-K |
Report
|
LIVE FILING |
Sep 4, 2014 |
Sep 4, 2014 |
| 6-K |
Report
|
LIVE FILING |
Sep 4, 2014 |
Sep 4, 2014 |
| 6-K |
Report
|
LIVE FILING |
Sep 3, 2014 |
Sep 3, 2014 |
| 6-K |
Report
|
LIVE FILING |
Sep 3, 2014 |
Sep 3, 2014 |
| 6-K |
Report
|
LIVE FILING |
Sep 3, 2014 |
Sep 3, 2014 |
| 6-K |
Report
|
LIVE FILING |
Sep 2, 2014 |
Sep 2, 2014 |
| 6-K |
Report
|
LIVE FILING |
Aug 7, 2014 |
Aug 7, 2014 |
| 6-K |
Report
| Data |
FORM 6-K |
Jul 31, 2014 |
Jul 31, 2014 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K |
Jul 31, 2014 |
Jul 31, 2014 |
| 6-K |
Report
|
LIVE FILING |
Jul 30, 2014 |
Jul 30, 2014 |
| 6-K |
Report
|
LIVE FILING |
Jul 21, 2014 |
Jul 21, 2014 |
| 6-K |
Report
|
LIVE FILING |
Jul 18, 2014 |
Jul 18, 2014 |
| 6-K |
Report
|
LIVE FILING |
Jul 16, 2014 |
Jul 16, 2014 |
| 6-K |
Report
|
LIVE FILING |
Jul 14, 2014 |
Jul 14, 2014 |
| 6-K |
Report
|
FORM 6-K |
Jul 3, 2014 |
Jul 3, 2014 |
| 6-K |
Report
|
FORM 6-K |
Jul 3, 2014 |
Jul 3, 2014 |
| 6-K |
Report
|
LIVE FILING |
Jun 20, 2014 |
Jun 20, 2014 |
| 6-K |
Report
|
FORM 6-K |
Jun 18, 2014 |
Jun 18, 2014 |
| 6-K |
Report
|
FORM 6-K |
Jun 18, 2014 |
Jun 18, 2014 |
| 6-K |
Report
|
LIVE FILING |
Jun 17, 2014 |
Jun 17, 2014 |
| 6-K |
Report
|
LIVE FILING |
Jun 12, 2014 |
Jun 12, 2014 |
| 6-K |
Report
|
LIVE FILING |
Jun 9, 2014 |
Jun 9, 2014 |
| 6-K |
Report
|
LIVE FILING |
Jun 5, 2014 |
Jun 5, 2014 |
| 6-K |
Report
|
LIVE FILING |
Jun 3, 2014 |
Jun 3, 2014 |
| 6-K |
Report
|
LIVE FILING |
Jun 2, 2014 |
Jun 2, 2014 |
| 6-K |
Report
|
LIVE FILING |
May 30, 2014 |
May 30, 2014 |
| 6-K |
Report
|
LIVE FILING |
May 29, 2014 |
May 29, 2014 |
| 6-K |
Report
|
LIVE FILING |
May 27, 2014 |
May 27, 2014 |
| 6-K |
Report
|
LIVE FILING |
May 23, 2014 |
May 23, 2014 |
| 6-K |
Report
|
LIVE FILING |
May 15, 2014 |
May 15, 2014 |
| 6-K |
Report
|
LIVE FILING |
May 13, 2014 |
May 13, 2014 |
| 6-K |
Report
|
LIVE FILING |
May 9, 2014 |
May 9, 2014 |
| 6-K |
Report
|
LIVE FILING |
May 8, 2014 |
May 8, 2014 |
| 6-K |
Report
|
LIVE FILING |
May 5, 2014 |
May 5, 2014 |
| 6-K |
Report
| Data |
6-K |
May 2, 2014 |
May 1, 2014 |
| 6-K/A |
Report
|
6-K/A |
May 1, 2014 |
May 1, 2014 |
| 6-K |
Report
|
LIVE FILING |
May 1, 2014 |
May 1, 2014 |
| 6-K |
Report
|
LIVE FILING |
Apr 30, 2014 |
Apr 30, 2014 |
| 6-K |
Report
|
LIVE FILING |
Apr 30, 2014 |
Apr 30, 2014 |
| 6-K |
Report
|
LIVE FILING |
Apr 30, 2014 |
Apr 30, 2014 |
| 6-K |
Report
|
LIVE FILING |
Apr 29, 2014 |
Apr 29, 2014 |
| 6-K |
Report
|
LIVE FILING |
Apr 28, 2014 |
Apr 28, 2014 |
| 6-K |
Report
|
LIVE FILING |
Apr 28, 2014 |
Apr 28, 2014 |
| 6-K |
Report
|
LIVE FILING |
Apr 24, 2014 |
Apr 24, 2014 |
| 6-K |
Report
|
LIVE FILING |
Apr 21, 2014 |
Apr 21, 2014 |
| 6-K |
Report
|
LIVE FILING |
Apr 15, 2014 |
Apr 15, 2014 |
| 6-K |
Report
|
LIVE FILING |
Apr 8, 2014 |
Apr 8, 2014 |
| 6-K |
Report
|
LIVE FILING |
Mar 31, 2014 |
Mar 31, 2014 |
| 6-K |
Report
|
LIVE FILING |
Mar 20, 2014 |
Mar 20, 2014 |
| 6-K |
Report
|
LIVE FILING |
Mar 13, 2014 |
Mar 13, 2014 |
| 6-K |
Report
|
LIVE FILING |
Mar 7, 2014 |
Mar 7, 2014 |
| 6-K |
Report
|
LIVE FILING |
Mar 4, 2014 |
Mar 4, 2014 |
| 6-K |
Report
|
LIVE FILING |
Mar 3, 2014 |
Mar 3, 2014 |
| 6-K |
Report
|
LIVE FILING |
Feb 28, 2014 |
Feb 28, 2014 |
| 6-K |
Report
|
LIVE FILING |
Feb 24, 2014 |
Feb 24, 2014 |
| 6-K |
Report
|
LIVE FILING |
Feb 24, 2014 |
Feb 24, 2014 |
| 6-K |
Report
|
LIVE FILING |
Feb 24, 2014 |
Feb 24, 2014 |
| 6-K |
Report
|
LIVE FILING |
Feb 21, 2014 |
Feb 21, 2014 |
| 6-K |
Report
|
FORM 6-K |
Feb 21, 2014 |
Feb 21, 2014 |
| 6-K |
Report
|
LIVE FILING |
Feb 13, 2014 |
Feb 13, 2014 |
| SC 13G |
Report
|
SC 13G |
Feb 13, 2014 |
|
| 20-F |
Report
| Data |
FORM 20-F |
Feb 10, 2014 |
Dec 31, 2013 |
| 6-K |
Report
|
FORM 6-K |
Feb 6, 2014 |
Feb 6, 2014 |
| 6-K |
Report
|
LIVE FILING |
Jan 29, 2014 |
Jan 28, 2014 |
| 6-K |
Report
|
LIVE FILING |
Jan 24, 2014 |
Jan 24, 2014 |
| 6-K |
Report
|
LIVE FILING |
Jan 22, 2014 |
Jan 22, 2014 |
| 6-K |
Report
|
LIVE FILING |
Jan 21, 2014 |
Jan 21, 2014 |
| 6-K |
Report
|
FORM 6-K |
Jan 17, 2014 |
Jan 17, 2014 |
| 6-K |
Report
|
LIVE FILING |
Jan 13, 2014 |
Jan 13, 2014 |
| 6-K |
Report
|
LIVE FILING |
Jan 9, 2014 |
Jan 9, 2014 |
| 6-K |
Report
|
LIVE FILING |
Jan 9, 2014 |
Jan 9, 2014 |
| 6-K |
Report
|
LIVE FILING |
Jan 3, 2014 |
Jan 3, 2014 |
| 6-K |
Report
|
LIVE FILING |
Dec 24, 2013 |
Dec 24, 2013 |
| 6-K |
Report
|
LIVE FILING |
Dec 19, 2013 |
Dec 19, 2013 |
| 6-K |
Report
|
LIVE FILING |
Dec 17, 2013 |
Dec 17, 2013 |
| 6-K |
Report
|
LIVE FILING |
Dec 10, 2013 |
Dec 10, 2013 |
| 6-K |
Report
|
LIVE FILING |
Dec 10, 2013 |
Dec 10, 2013 |
| 6-K |
Report
|
LIVE FILING |
Dec 4, 2013 |
Dec 4, 2013 |
| 6-K |
Report
|
LIVE FILING |
Dec 4, 2013 |
Dec 4, 2013 |
| 6-K |
Report
|
LIVE FILING |
Dec 4, 2013 |
Dec 4, 2013 |
| 6-K |
Report
|
LIVE FILING |
Dec 4, 2013 |
Dec 4, 2013 |
| 6-K |
Report
|
LIVE FILING |
Nov 27, 2013 |
Nov 27, 2013 |
| 6-K |
Report
|
LIVE FILING |
Nov 25, 2013 |
Nov 25, 2013 |
| 6-K |
Report
|
LIVE FILING |
Nov 25, 2013 |
Nov 25, 2013 |
| 6-K |
Report
|
LIVE FILING |
Nov 19, 2013 |
Nov 19, 2013 |
| 6-K |
Report
|
LIVE FILING |
Nov 18, 2013 |
Nov 18, 2013 |
| 6-K |
Report
|
LIVE FILING |
Nov 12, 2013 |
Nov 12, 2013 |
| 6-K |
Report
|
LIVE FILING |
Nov 8, 2013 |
Nov 8, 2013 |
| 6-K |
Report
|
LIVE FILING |
Nov 6, 2013 |
Nov 6, 2013 |
| 6-K |
Report
| Data |
FORM 6-K |
Oct 31, 2013 |
Oct 31, 2013 |
| 6-K |
Report
|
LIVE FILING |
Oct 31, 2013 |
Oct 31, 2013 |
| 6-K |
Report
|
LIVE FILING |
Oct 30, 2013 |
Oct 30, 2013 |
| 6-K |
Report
|
LIVE FILING |
Oct 10, 2013 |
Oct 10, 2013 |
| 6-K |
Report
|
LIVE FILING |
Oct 10, 2013 |
Oct 10, 2013 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K |
Oct 9, 2013 |
Oct 8, 2013 |
| 6-K |
Report
|
LIVE FILING |
Oct 4, 2013 |
Oct 4, 2013 |
| 6-K |
Report
|
LIVE FILING |
Oct 3, 2013 |
Oct 3, 2013 |
| 6-K |
Report
|
LIVE FILING |
Oct 3, 2013 |
Oct 3, 2013 |
| 6-K |
Report
|
LIVE FILING |
Oct 1, 2013 |
Oct 1, 2013 |
| 6-K |
Report
|
LIVE FILING |
Oct 1, 2013 |
Oct 1, 2013 |
| 6-K |
Report
|
LIVE FILING |
Sep 30, 2013 |
Sep 30, 2013 |
| 6-K |
Report
|
LIVE FILING |
Sep 26, 2013 |
Sep 26, 2013 |
| 6-K |
Report
|
LIVE FILING |
Sep 24, 2013 |
Sep 24, 2013 |
| 6-K |
Report
|
LIVE FILING |
Sep 23, 2013 |
Sep 23, 2013 |
| 6-K |
Report
|
LIVE FILING |
Sep 20, 2013 |
Sep 20, 2013 |
| 6-K |
Report
|
LIVE FILING |
Sep 17, 2013 |
Sep 17, 2013 |
| 6-K |
Report
|
LIVE FILING |
Sep 16, 2013 |
Sep 16, 2013 |
| 6-K |
Report
|
LIVE FILING |
Aug 30, 2013 |
Aug 30, 2013 |
| 6-K |
Report
|
LIVE FILING |
Aug 27, 2013 |
Aug 27, 2013 |
| 6-K |
Report
|
LIVE FILING |
Aug 14, 2013 |
Aug 14, 2013 |
| 6-K |
Report
|
LIVE FILING |
Aug 12, 2013 |
Aug 12, 2013 |
| 6-K |
Report
|
LIVE FILING |
Aug 8, 2013 |
Aug 8, 2013 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K |
Aug 7, 2013 |
Aug 7, 2013 |
| 6-K |
Report
|
LIVE FILING |
Aug 1, 2013 |
Aug 1, 2013 |
| 6-K |
Report
| Data |
FORM 6-K |
Aug 1, 2013 |
Aug 1, 2013 |
| 6-K |
Report
|
LIVE FILING |
Jul 29, 2013 |
Jul 29, 2013 |
| 6-K |
Report
|
LIVE FILING |
Jul 29, 2013 |
Jul 29, 2013 |
| 6-K |
Report
|
LIVE FILING |
Jul 26, 2013 |
Jul 26, 2013 |
| 6-K |
Report
|
LIVE FILING |
Jul 25, 2013 |
Jul 25, 2013 |
| 6-K |
Report
|
LIVE FILING |
Jul 23, 2013 |
Jul 23, 2012 |
| 6-K |
Report
|
FORM 6-K |
Jul 18, 2013 |
Jul 18, 2013 |
| 6-K |
Report
|
LIVE FILING |
Jul 10, 2013 |
Jul 10, 2013 |
| 6-K |
Report
|
LIVE FILING |
Jul 9, 2013 |
Jul 9, 2013 |
| 6-K |
Report
|
LIVE FILING |
Jul 1, 2013 |
Jul 1, 2013 |
| 6-K |
Report
|
LIVE FILING |
Jun 24, 2013 |
Jun 24, 2013 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K |
Jun 20, 2013 |
Jun 19, 2013 |
| 6-K |
Report
|
LIVE FILING |
Jun 17, 2013 |
Jun 17, 2013 |
| 6-K |
Report
|
LIVE FILING |
Jun 12, 2013 |
Jun 12, 2013 |
| 6-K |
Report
|
LIVE FILING |
Jun 12, 2013 |
Jun 12, 2013 |
| 6-K |
Report
|
LIVE FILING |
Jun 3, 2013 |
Jun 3, 2013 |
| 6-K |
Report
|
LIVE FILING |
May 30, 2013 |
May 30, 2013 |
| 6-K |
Report
|
LIVE FILING |
May 30, 2013 |
May 30, 2013 |
| 6-K |
Report
|
LIVE FILING |
May 10, 2013 |
May 8, 2013 |
| 6-K |
Report
|
LIVE FILING |
May 8, 2013 |
May 8, 2013 |
| 6-K |
Report
|
LIVE FILING |
May 6, 2013 |
May 6, 2013 |
| 6-K |
Report
| Data |
FORM 6-K |
May 2, 2013 |
May 2, 2013 |
| 6-K |
Report
|
LIVE FILING |
May 2, 2013 |
May 2, 2013 |
| 6-K |
Report
|
LIVE FILING |
May 1, 2013 |
Apr 30, 2013 |
| 6-K |
Report
|
LIVE FILING |
Apr 29, 2013 |
Apr 29, 2013 |
| 6-K |
Report
|
LIVE FILING |
Apr 25, 2013 |
Apr 24, 2013 |
| 6-K |
Report
|
LIVE FILING |
Apr 23, 2013 |
Apr 23, 2013 |
| 6-K |
Report
|
LIVE FILING |
Apr 17, 2013 |
Apr 17, 2013 |
| 6-K |
Report
|
LIVE FILING |
Apr 8, 2013 |
Apr 8, 2013 |
| 6-K |
Report
|
LIVE FILING |
Apr 8, 2013 |
Apr 8, 2013 |
| 6-K |
Report
|
LIVE FILING |
Mar 29, 2013 |
Mar 29, 2013 |
| 6-K |
Report
|
LIVE FILING |
Mar 21, 2013 |
Mar 21, 2013 |
| 6-K |
Report
|
LIVE FILING |
Mar 20, 2013 |
Mar 20, 2013 |
| 6-K |
Report
|
LIVE FILING |
Mar 14, 2013 |
Mar 14, 2013 |
| 6-K |
Report
|
LIVE FILING |
Mar 8, 2013 |
Mar 8, 2013 |
| 6-K |
Report
|
LIVE FILING |
Mar 6, 2013 |
Mar 6, 2013 |
| 6-K |
Report
|
LIVE FILING |
Mar 4, 2013 |
Mar 4, 2013 |
| 6-K |
Report
|
LIVE FILING |
Feb 22, 2013 |
Feb 22, 2013 |
| 6-K |
Report
|
LIVE FILING |
Feb 14, 2013 |
Feb 14, 2013 |
| 20-F |
Report
| Data |
FORM 20-F |
Feb 12, 2013 |
Dec 31, 2012 |
| 6-K |
Report
|
LIVE FILING |
Feb 11, 2013 |
Feb 11, 2013 |
| 6-K |
Report
|
LIVE FILING |
Feb 7, 2013 |
Feb 7, 2013 |
| 6-K |
Report
|
LIVE FILING |
Feb 5, 2013 |
Feb 5, 2013 |
| 6-K |
Report
|
LIVE FILING |
Jan 31, 2013 |
Jan 31, 2013 |
| 6-K |
Report
|
LIVE FILING |
Jan 23, 2013 |
Jan 23, 2012 |
| 6-K |
Report
|
FORM 6-K |
Dec 20, 2012 |
Dec 19, 2012 |
| 6-K |
Report
|
LIVE FILING |
Dec 18, 2012 |
Dec 18, 2012 |
| 6-K |
Report
|
LIVE FILING |
Dec 18, 2012 |
Dec 18, 2012 |
| 6-K |
Report
|
FORM 6-K |
Dec 18, 2012 |
Dec 18, 2012 |
| 6-K |
Report
|
LIVE FILING |
Dec 17, 2012 |
Dec 17, 2012 |
| 6-K |
Report
|
LIVE FILING |
Dec 14, 2012 |
Dec 13, 2012 |
| 6-K |
Report
|
LIVE FILING |
Dec 13, 2012 |
Dec 13, 2012 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K |
Dec 11, 2012 |
Dec 11, 2012 |
| 6-K |
Report
|
LIVE FILING |
Dec 11, 2012 |
Dec 11, 2012 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K |
Dec 5, 2012 |
Nov 30, 2012 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K |
Nov 30, 2012 |
Nov 30, 2012 |
| 6-K |
Report
|
LIVE FILING |
Nov 26, 2012 |
Nov 26, 2012 |
| 6-K |
Report
|
LIVE FILING |
Nov 9, 2012 |
Nov 9, 2012 |
| 6-K |
Report
|
LIVE FILING |
Nov 5, 2012 |
Nov 5, 2012 |
| 6-K |
Report
| Data |
FORM 6-K |
Nov 1, 2012 |
Nov 1, 2012 |
| 6-K |
Report
|
LIVE FILING |
Nov 1, 2012 |
Nov 1, 2012 |
| 6-K |
Report
|
LIVE FILING |
Oct 26, 2012 |
Oct 26, 2012 |
| 6-K |
Report
|
LIVE FILING |
Oct 25, 2012 |
Oct 24, 2012 |
| 6-K |
Report
|
LIVE FILING |
Oct 25, 2012 |
Oct 23, 2012 |
| 6-K |
Report
|
LIVE FILING |
Oct 25, 2012 |
Oct 25, 2012 |
| 6-K |
Report
|
LIVE FILING |
Oct 22, 2012 |
Oct 22, 2012 |
| 6-K |
Report
|
LIVE FILING |
Oct 22, 2012 |
Oct 22, 2012 |
| 6-K |
Report
|
LIVE FILING |
Oct 18, 2012 |
Oct 18, 2012 |
| 6-K |
Report
|
LIVE FILING |
Oct 18, 2012 |
Oct 18, 2010 |
| 6-K |
Report
|
LIVE FILING |
Oct 10, 2012 |
Oct 8, 2012 |
| 6-K |
Report
|
LIVE FILING |
Oct 10, 2012 |
Oct 10, 2012 |
| 6-K |
Report
|
LIVE FILING |
Sep 27, 2012 |
Sep 27, 2012 |
| 6-K |
Report
|
LIVE FILING |
Sep 17, 2012 |
Sep 14, 2012 |
| 6-K |
Report
|
LIVE FILING |
Sep 13, 2012 |
Sep 13, 2012 |
| 6-K |
Report
|
LIVE FILING |
Sep 13, 2012 |
Sep 13, 2012 |
| 6-K |
Report
|
LIVE FILING |
Aug 30, 2012 |
Aug 30, 2012 |
| 6-K |
Report
|
LIVE FILING |
Aug 17, 2012 |
Aug 17, 2012 |
| 6-K |
Report
|
LIVE FILING |
Aug 17, 2012 |
Aug 17, 2012 |
| 6-K |
Report
|
LIVE FILING |
Aug 8, 2012 |
Aug 8, 2012 |
| 6-K |
Report
|
FORM 6-K |
Aug 8, 2012 |
Aug 8, 2012 |
| 6-K |
Report
|
LIVE FILING |
Aug 6, 2012 |
Aug 2, 2012 |
| 6-K |
Report
|
LIVE FILING |
Aug 6, 2012 |
Aug 3, 2012 |
| 6-K |
Report
|
LIVE FILING |
Aug 2, 2012 |
Aug 2, 2012 |
| 6-K |
Report
| Data |
FORM 6-K |
Aug 2, 2012 |
Aug 2, 2012 |
| 6-K |
Report
|
LIVE FILING |
Jul 2, 2012 |
Jun 29, 2012 |
| 6-K |
Report
|
LIVE FILING |
Jun 21, 2012 |
Jun 21, 2012 |
| 6-K |
Report
|
LIVE FILING |
Jun 19, 2012 |
Jun 14, 2012 |
| 6-K |
Report
|
LIVE FILING |
Jun 19, 2012 |
Jun 13, 2012 |
| 6-K |
Report
|
LIVE FILING |
Jun 8, 2012 |
Jun 8, 2012 |
| 6-K |
Report
|
LIVE FILING |
Jun 1, 2012 |
Jun 1, 2012 |
| 6-K |
Report
|
LIVE FILING |
May 24, 2012 |
May 24, 2012 |
| 6-K |
Report
|
LIVE FILING |
May 23, 2012 |
May 23, 2012 |
| 6-K |
Report
|
LIVE FILING |
May 17, 2012 |
May 17, 2012 |
| 6-K |
Report
| Data |
FORM 6-K |
May 9, 2012 |
May 9, 2012 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K |
May 9, 2012 |
May 9, 2012 |
| 6-K |
Report
|
LIVE FILING |
May 8, 2012 |
May 8, 2012 |
| 6-K |
Report
|
LIVE FILING |
May 8, 2012 |
May 8, 2012 |
| 6-K |
Report
|
LIVE FILING |
May 1, 2012 |
Apr 30, 2012 |
| 6-K |
Report
|
LIVE FILING |
Apr 27, 2012 |
Apr 26, 2012 |
| 6-K |
Report
|
FORM 6-K |
Apr 25, 2012 |
Apr 25, 2012 |
| 6-K |
Report
|
LIVE FILING |
Apr 20, 2012 |
Apr 2, 2012 |
| 6-K |
Report
|
LIVE FILING |
Apr 18, 2012 |
Apr 18, 2012 |
| 6-K |
Report
|
LIVE FILING |
Apr 5, 2012 |
Apr 5, 2012 |
| 6-K |
Report
|
FORM 6-K |
Apr 4, 2012 |
Apr 4, 2012 |
| 6-K |
Report
|
LIVE FILING |
Apr 4, 2012 |
Apr 4, 2012 |
| 6-K |
Report
|
LIVE FILING |
Mar 28, 2012 |
Mar 28, 2012 |
| 6-K |
Report
|
LIVE FILING |
Mar 23, 2012 |
Mar 22, 2012 |
| 6-K |
Report
|
LIVE FILING |
Mar 21, 2012 |
Mar 21, 2012 |
| 6-K |
Report
|
LIVE FILING |
Mar 16, 2012 |
Mar 15, 2012 |
| 6-K |
Report
|
LIVE FILING |
Mar 14, 2012 |
Mar 14, 2012 |
| 6-K |
Report
|
LIVE FILING |
Mar 8, 2012 |
Mar 8, 2012 |
| 6-K |
Report
|
LIVE FILING |
Mar 8, 2012 |
Mar 8, 2012 |
| 6-K |
Report
|
LIVE FILING |
Mar 6, 2012 |
Mar 6, 2012 |
| 6-K |
Report
|
LIVE FILING |
Mar 5, 2012 |
Mar 2, 2012 |
| 6-K |
Report
|
LIVE FILING |
Mar 2, 2012 |
Mar 2, 2012 |
| 20-F |
Report
| Data |
FORM 20-F |
Feb 17, 2012 |
Dec 31, 2011 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K |
Feb 15, 2012 |
Feb 15, 2012 |
| SC 13G |
Report
|
SCHEDULE 13G |
Feb 14, 2012 |
|
| 6-K |
Report
|
LIVE FILING |
Jan 17, 2012 |
Jan 17, 2012 |
| 6-K |
Report
|
LIVE FILING |
Jan 3, 2012 |
Jan 1, 2012 |
| 6-K |
Report
|
LIVE FILING |
Jan 3, 2012 |
Jan 3, 2012 |
| 6-K |
Report
|
LIVE FILING |
Dec 21, 2011 |
Dec 21, 2011 |
| 6-K |
Report
|
LIVE FILING |
Dec 8, 2011 |
Dec 8, 2011 |
| 6-K |
Report
|
LIVE FILING |
Dec 2, 2011 |
Dec 1, 2011 |
| 6-K |
Report
|
LIVE FILING |
Dec 1, 2011 |
Dec 1, 2011 |
| 6-K |
Report
|
LIVE FILING |
Dec 1, 2011 |
Nov 30, 2011 |
| 6-K |
Report
|
FORM 6-K |
Nov 10, 2011 |
Nov 10, 2011 |
| 6-K |
Report
|
LIVE FILING |
Nov 8, 2011 |
Nov 7, 2011 |
| 6-K |
Report
| Data |
FORM 6-K |
Nov 2, 2011 |
Nov 2, 2011 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K |
Nov 2, 2011 |
Oct 31, 2011 |
| 6-K |
Report
|
LIVE FILING |
Nov 2, 2011 |
Nov 2, 2011 |
| 6-K |
Report
|
LIVE FILING |
Nov 2, 2011 |
Nov 2, 2011 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K |
Nov 2, 2011 |
Nov 2, 2011 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K |
Oct 25, 2011 |
Oct 24, 2011 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K |
Oct 24, 2011 |
Oct 20, 2011 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K |
Oct 19, 2011 |
Oct 19, 2011 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K |
Oct 14, 2011 |
Oct 14, 2011 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K |
Oct 14, 2011 |
Oct 14, 2011 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K |
Oct 13, 2011 |
Oct 13, 2011 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LTD. 6-K |
Oct 11, 2011 |
Oct 11, 2011 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6K |
Oct 11, 2011 |
Oct 10, 2011 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K |
Oct 11, 2011 |
Oct 10, 2011 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K |
Oct 6, 2011 |
Oct 6, 2011 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K |
Sep 21, 2011 |
Sep 21, 2011 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K |
Sep 20, 2011 |
Sep 20, 2011 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K |
Sep 13, 2011 |
Sep 7, 2011 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K |
Sep 13, 2011 |
Sep 13, 2011 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K |
Sep 12, 2011 |
Sep 12, 2011 |
| 6-K |
Report
|
TEVA ANNOUNCES COURT ADOPTS ALL RELEVANT TEVA CLAIM CONSTRUCTION INTERPRETATIONS |
Sep 6, 2011 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA RECEIVES FDA ACCEPTANCE OF ITS NEW DRUG APPLICATION FOR BDP NASAL HFA FOR T |
Aug 8, 2011 |
Apr 1, 2009 |
| 6-K |
Report
|
FORM 6-K |
Aug 4, 2011 |
Aug 4, 2011 |
| 6-K |
Report
|
TEVA RECEIVES EUROPEAN MARKETING AUTHORIZATION FOR ZOELY??? ORAL CONTRACEPTIVE |
Aug 2, 2011 |
Apr 1, 2009 |
| 6-K |
Report
|
RESULTS OF PHASE III BRAVO TRIAL REINFORCE UNIQUE PROFILE OF LAQUINIMOD FOR MULT |
Aug 2, 2011 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA ANNOUNCES LAUNCH OF CAMRESE??? THE AUTHORIZED GENERIC OF SEASONIQUE? |
Aug 2, 2011 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA ANNOUNCES LAUNCH OF CAMRESE??? THE AUTHORIZED GENERIC OF SEASONIQUE? |
Aug 1, 2011 |
Apr 1, 2009 |
| 6-K |
Report
| Data |
FORM 6-K |
Jul 28, 2011 |
Jul 28, 2011 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K |
Jul 27, 2011 |
Jul 27, 2011 |
| 6-K |
Report
|
TEVA ANNOUNCES PATENT LITIGATION |
Jul 21, 2011 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA TO REPORT SECOND QUARTER 2011 FINANCIAL RESULTS ON JULY 27, 2011 |
Jul 13, 2011 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA COMMENTS ON SUPREME COURT DECISION |
Jul 13, 2011 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA COMMENTS ON SUPREME COURT DECISION |
Jun 27, 2011 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA ANNOUNCES SUCCESSFUL RESULTS OF PHASE III STUDY OF ITS LONG-ACTING G CSF PR |
Jun 21, 2011 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA AND PFIZER SETTLE GENERIC NEURONTIN? LITIGATION |
Jun 21, 2011 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA AND CEPHALON RECEIVE FTC REQUEST FOR ADDITIONAL INFORMATION |
Jun 14, 2011 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA SIGNS $4 BILLION SYNDICATED CREDIT FACILITIES |
Jun 13, 2011 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K |
Jun 7, 2011 |
Jun 7, 2011 |
| 6-K |
Report
|
TEVA ANNOUNCES LAUNCH OF GENERIC ARICEPT? TABLETS IN THE UNITED STATES |
Jun 2, 2011 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA COMPLETES ENROLLMENT IN PHASE III MULTIPLE SCLEROSIS TRIAL EVALUATING GLATI |
Jun 2, 2011 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA ANNOUNCES APPROVAL OF GENERIC COMBIVIR TABLETS: LAUNCH EXPECTED IN FOURTH Q |
May 31, 2011 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA ANNOUNCES DATA ON GRANULOCYTE COLONY STIMULATING FACTOR COMPOUNDS FOR THE P |
May 31, 2011 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA AND ONCOGENEX TO PRESENT DATA ON CUSTIRSEN IN PROSTATE CANCER AT THE 2011 A |
May 19, 2011 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA AND CURETECH ANNOUNCE POSITIVE PHASE II DATA FROM CT-011, AN INVESTIGATIONA |
May 17, 2011 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA TO ACQUIRE TAIYO |
May 17, 2011 |
Apr 1, 2009 |
| 6-K |
Report
| Data |
FORM 6-K |
May 11, 2011 |
May 11, 2011 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K |
May 11, 2011 |
May 11, 2011 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K |
May 3, 2011 |
May 3, 2011 |
| 6-K |
Report
|
TEVA TO ACQUIRE CEPHALON IN $6.8 BILLION TRANSACTION |
May 2, 2011 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA PROVIDES UPDATE ON COMPANY ACTIVITIES |
Apr 26, 2011 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LTD. MAKES STATEMENT ON DEFINE STUDY RESULTS |
Apr 25, 2011 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA TO REPORT FIRST QUARTER 2011 FINANCIAL RESULTS ON MAY 11, 2011 |
Apr 25, 2011 |
Apr 1, 2009 |
| 6-K |
Report
|
NEW STUDY DEMONSTRATED SIGNIFICANT REDUCTION IN ANNUALIZED RELAPSE RATE AND HALT |
Apr 25, 2011 |
Apr 1, 2009 |
| 6-K |
Report
|
ORAL LAQUINIMOD FOR MULTIPLE SCLEROSIS TREATMENT SIGNIFICANTLY REDUCED DISEASE A |
Apr 12, 2011 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA ANNOUNCES PRESENTATION OF NEW DATA ON MULTIPLE SCLEROSIS AND PARKINSON???S |
Apr 11, 2011 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA AND ONCOGENEX PRESENT PRECLINICAL DATA ON THE ACTIVITY OF ITS ANTISENSE COM |
Apr 7, 2011 |
Apr 1, 2009 |
| 6-K |
Report
|
THE PROCTER & GAMBLE COMPANY AND TEVA PHARMACEUTICAL INDUSTRIES FORM CONSUMER HE |
Mar 24, 2011 |
Apr 1, 2009 |
| 6-K |
Report
|
FORM 6-K |
Mar 21, 2011 |
Mar 16, 2011 |
| 6-K |
Report
|
TEVA ANNOUNCES PRICING OF $750,000,000 OF SENIOR NOTES |
Mar 17, 2011 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA ANNOUNCES TRIAL DATE IN GENERIC COPAXONE? LITIGATION |
Mar 1, 2011 |
Apr 1, 2009 |
| 20-F |
Report
| Data |
FORM 20F |
Feb 15, 2011 |
Dec 31, 2010 |
| 6-K |
Report
|
NOTICE |
Feb 10, 2011 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA ANNOUNCES RESULTS FROM A PHASE III STUDY FOR QNAZE??? NASAL AEROSOL IN PERE |
Feb 9, 2011 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA PROVIDES 2011 NON-GAAP FINANCIAL OUTLOOK |
Feb 8, 2011 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LTD. 6-K |
Feb 8, 2011 |
Feb 8, 2011 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K |
Feb 2, 2011 |
Feb 2, 2011 |
| SC 13G |
Report
|
SC 13G |
Jan 28, 2011 |
|
| 6-K |
Report
|
TEVA TO ACQUIRE CORPORACI?N INFARMASA |
Jan 27, 2011 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA AND APP ANNOUNCE LAUNCH OF GENERIC GEMZAR?; PURSUANT TO AGREEMENT |
Jan 26, 2011 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA RECEIVES FDA ACTION LETTER FOR GENERIC LOVENOX? |
Jan 25, 2011 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA ENTERS INTO $1.5 BILLION SYNDICATED CREDIT FACILITY |
Jan 25, 2011 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA CONGRATULATES PROFESSOR MOUSSA YOUDIM, WINNER OF THE 2010 EMET PRIZE FOR BR |
Jan 19, 2011 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA CALLS 1.75% CONVERTIBLE DEBENTURES DUE 2026 FOR REDEMPTION |
Jan 11, 2011 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA TO REPORT FOURTH QUARTER AND FULL YEAR 2010 FINANCIAL RESULTS ON FEBRUARY 8 |
Jan 11, 2011 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA PROVIDES UPDATE ON VENLAFAXINE HCL ER |
Jan 10, 2011 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA COMPLETES ACQUISITION OF THERAMEX |
Jan 5, 2011 |
Apr 1, 2009 |
| 6-K |
Report
|
FDA ISSUES COMPLETE RESPONSE LETTER FOR LOWER-VOLUME GLATIRAMER ACETATE SNDA |
Dec 23, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA AND TAKEDA SETTLE GENERIC ACTOS? AND ACTOPLUS MET? LITIGATION |
Dec 23, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA FILES CITIZEN PETITION SURROUNDING PURPORTED GENERIC VERSION OF COPAXONE? |
Dec 14, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA ANNOUNCES SUCCESSFUL RESULTS OF PHASE III STUDY WITH ORAL LAQUINIMOD FOR MU |
Dec 9, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA ANNOUNCES $1 BILLION SHARE REPURCHASE PROGRAM |
Dec 6, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA ANNOUNCES $1 BILLION SHARE REPURCHASE PROGRAM |
Dec 1, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA HIGHLIGHTS QNAZE??? HFA PHASE III DATA AT THE 2010 ANNUAL MEETING OF THE AM |
Nov 15, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA PRESENTS RESPIRATORY GROWTH STRATEGY |
Nov 5, 2010 |
Apr 1, 2009 |
| 6-K |
Report
| Data |
FORM 6-K |
Nov 2, 2010 |
Nov 2, 2010 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED - 6-K |
Nov 2, 2010 |
Nov 2, 2010 |
| 6-K |
Report
|
TEVA TO ACQUIRE THERAMEX, MERCK KGAA???S EUROPEAN BASED WOMEN???S HEALTH BUSINES |
Oct 28, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
EARLY INITIATION OF TREATMENT WITH COPAXONE? PROVIDES GREATER EFFECTS IN DELAYIN |
Oct 19, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
EARLY INITIATION OF TREATMENT WITH COPAXONE? PROVIDES GREATER EFFECTS IN DELAYIN |
Oct 19, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
NEW DATA EVALUATING LAQUINIMOD FOR THE TREATMENT OF MULTIPLE SCLEROSIS DEMONSTRA |
Oct 18, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA TO REPORT THIRD QUARTER 2010 FINANCIAL RESULTS ON NOVEMBER 2, 2010 |
Oct 13, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA TO PRESENT NEW DATA ON COPAXONE? AND LAQUINIMOD AT THE 26TH ANNUAL ECTRIMS |
Oct 6, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA FILES SUIT ON PIV FILINGS FOR AZILECT? |
Oct 4, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
ORAL LAQUINIMOD DEMONSTRATED SUSTAINED EFFICACY AND SAFETY IN PATIENTS WITH MULT |
Sep 21, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K |
Sep 7, 2010 |
Sep 7, 2010 |
| 6-K |
Report
|
TEVA COMPLETES ACQUISITION OF RATIOPHARM |
Aug 10, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA RECEIVES EUROPEAN COMMISSION APPROVAL FOR RATIOPHARM ACQUISITION |
Aug 5, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA RECEIVES EUROPEAN COMMISSION APPROVAL FOR RATIOPHARM ACQUISITION |
Aug 4, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA ANNOUNCES AGREEMENT WITH COMPETITION BUREAU OF CANADA REGARDING PROPOSED ME |
Aug 2, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
NOTICE ON CHAIM HURVITZ |
Jul 28, 2010 |
Apr 1, 2009 |
| 6-K |
Report
| Data |
FORM 6-K |
Jul 27, 2010 |
Jul 27, 2010 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K |
Jul 27, 2010 |
Jul 27, 2010 |
| 6-K |
Report
|
TEVA COMMENTS ON GENERIC LOVENOX? APPROVAL |
Jul 26, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
NOTICE |
Jul 20, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA PROVIDES UPDATE ON GENERIC PROTONIX? LITIGATION |
Jul 20, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA INTRODUCES FIRST GENERIC EFFEXOR XR? CAPSULES IN THE UNITED STATES; AWARDED |
Jul 1, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
NOTICE ON THE ANNUAL GENERAL MEETING |
Jun 30, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA ANNOUNCES APPROVAL OF GENERIC EFFEXOR XR? |
Jun 29, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA ANNOUNCES LAUNCH OF GENERIC ARIMIDEX? |
Jun 29, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA ANNOUNCES COMPLETION OF $2.5 BILLION OF SENIOR NOTES OFFERING |
Jun 21, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
FORM 6-K |
Jun 18, 2010 |
Jun 18, 2010 |
| 6-K |
Report
|
TEVA ANNOUNCES PRICING OF $2.5 BILLION OF SENIOR NOTES |
Jun 17, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
FORM 6-K |
Jun 15, 2010 |
Jun 15, 2010 |
| 6-K |
Report
|
TEVA ANNOUNCES LAUNCH OF GENERIC DIFFERIN? |
Jun 3, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA ANNOUNCES LAUNCH OF GENERIC YAZ? TABLETS |
Jun 1, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA ANNOUNCES LAUNCH OF GENERIC VALTREX? |
May 25, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA ANNOUNCES LAUNCH AND SHIPMENT OF GENERIC LIPITOR? TABLETS IN CANADA |
May 20, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA REACHES SETTLEMENT AGREEMENT WITH ASTRAZENECA REGARDING GENERIC ENTOCORT? E |
May 20, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
NOTICE OF ANNUAL MEETING OF SHAREHOLDERS |
May 18, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
6-K |
May 18, 2010 |
May 18, 2010 |
| 6-K |
Report
|
TEVA PROVIDES UPDATE ON TALAMPANEL FOR THE TREATMENTOF AMYOTROPHIC LATERAL SCLER |
May 17, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA ANNOUNCES TENTATIVE APPROVAL OF GENERIC SENSIPAR? |
May 17, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA PROVIDES UPDATE ON LAS VEGAS TRIAL |
May 10, 2010 |
Apr 1, 2009 |
| 6-K |
Report
| Data |
FORM 6-K |
May 4, 2010 |
May 4, 2010 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K |
May 4, 2010 |
May 4, 2010 |
| 6-K |
Report
|
TEVA TO PRESENT AT THE DEUTSCHE BANK 35TH ANNUAL HEALTHCARE CONFERENCE |
May 3, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA ANNOUNCES LAUNCH OF GENERIC FLOMAX? |
Apr 28, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA PROVIDES UPDATE ON GENERIC PROTONIX? LITIGATION |
Apr 26, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
ADAGIO ANALYSIS DEMONSTRATES THAT THE NATURAL PROGRESSION OF CLINICAL |
Apr 22, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
NEW DATA SUGGEST ORAL LAQUINIMOD MAY CONFER NEUROPROTECTION IN ADDITION TO IMMUN |
Apr 16, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA TO REPORT FIRST QUARTER 2010 FINANCIAL RESULTS ON MAY 4, 2010 |
Apr 15, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA ANNOUNCES COPAXONE? REACHES ONE MILLION PATIENT YEARS OF EXPERIENCE IN THE |
Apr 13, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA TO PRESENT NEW DATA ON MULTIPLE SCLEROSIS AND PARKINSON???S DISEASE AT THE |
Apr 8, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA ANNOUNCES FINAL APPROVAL OF GENERIC HYZAAR? AND COZAAR? |
Apr 8, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
3 PRESS RELEASES ISSUED ON APRIL 1, 2010 |
Apr 6, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
NOTICE |
Apr 6, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA ANNOUNCES TENTATIVE APPROVAL OF GENERIC ARGATROBAN? INJECTION |
Mar 25, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA TO ACQUIRE RATIOPHARM |
Mar 18, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA PROVIDES UPDATE ON GENERIC TEMODAR? |
Mar 17, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA ANNOUNCES THE APPOINTMENT OF DR. PHILIP FROST AS CHAIRMAN OF ITS BOARD OF D |
Mar 9, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA ANNOUNCES FAVORABLE COURT RULING IN GENERIC HYZAAR? AND COZAAR? LITIGATION |
Mar 2, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
COPAXONE? 15-YEAR STUDY IN MULTIPLE SCLEROSIS PATIENTS DEMONSTRATES ROBUST LONG- |
Feb 25, 2010 |
Apr 1, 2009 |
| 20-F |
Report
| Data |
FORM 20-F |
Feb 22, 2010 |
Dec 31, 2009 |
| 6-K |
Report
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K |
Feb 16, 2010 |
Feb 16, 2010 |
| 6-K |
Report
|
TEVA ANNOUNCES AGREEMENT ON FAMVIR? PATENT CHALLENGE |
Feb 16, 2010 |
Apr 1, 2009 |
| SC 13G/A |
Report
|
SC 13G/A |
Feb 11, 2010 |
|
| 6-K |
Report
|
TEVA ACQUIRES MARKETING RIGHTS FOR ORAL LAQUINIMOD IN THE NORDIC AND BALTIC REGI |
Feb 8, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA ANNOUNCES FDA ACCEPTS BLA FOR XM02 |
Feb 2, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA TO REPORT FOURTH QUARTER AND FULL YEAR 2009 FINANCIAL RESULTS ON FEBRUARY 1 |
Jan 19, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
MOODY'S UPGRADES TEVA RATING TO A3 |
Jan 14, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA ANNOUNCES SETTLEMENT AGREEMENTS WITH ASTRAZENECA REGARDING GENERIC PRILOSEC |
Jan 12, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
FDA APPROVES NEWLY REVISED PRESCRIBING INFORMATION FOR AZILECT REDUCING MEDICATI |
Jan 8, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
TEVA PRESENTS STRATEGIC PLAN TO DELIVER STRONG GROWTH AT INVESTOR MEETING |
Jan 8, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
FDA APPROVES NEWLY REVISED PRESCRIBING INFORMATION FOR AZILECT REDUCING MEDICATI |
Jan 7, 2010 |
Apr 1, 2009 |
| 6-K |
Report
|
NOTICE |
Jan 6, 2010 |
Apr 1, 2009 |